Efficient expression and mutation of avidin and streptavidin as host proteins for enantioselective catalysis by Zocchi, Andrea et al.
most likely plays a role as a host defense
factor [7][8]. The active form of hen-avidin
is a homotetramer composed of four singly
glycosylated subunits, containing one single
intramonomeric disulfide bridge. Each
monomer can bind a (+)-biotin (vitamin H)
molecule with an extraordinary affinity
(Ka= ~1014 M–1) [7]. Each subunit consists
of 128 amino acids and its primary se-
quence was determined in 1971 [9]. The
cDNA of the chicken oviduct avidin gene
was documented by Gope et al. [10] and a
genomic clone was isolated by Keinanen et
al. [11]. The primary source for the com-
mercial production of avidin has been ex-
traction and purification from chicken egg
white, but biologically active recombinant
isoforms have been produced in several ex-
pression systems, including E. coli [12]
[13], baculovirus-infected cells [14] and
maize [15]. The methylotrophic yeast
Pichia pastoris offers an attractive alterna-
tive to the above expression systems. This
expression system combines the advan-
tages of microbial and eukaryotic organ-
isms, namely the formation of disulfide
bridges, the glycosylation and the high-
density cell fermentation [16].
We expressed an optimized artificial
avidin gene in Pichia pastoris. The expres-
sion vector is integrated into the yeast ge-
nome. The plasmid we chose drives the
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As outlined in the preceding article [1], the
research in the Ward group is centered on
the incorporation of active catalyst precur-
sors in a well-defined protein environment
to afford selective catalysts. Rather than co-
valent anchoring, the biotin-avidin technol-
ogy is a straightforward method that en-
sures precise localization of a biotinylated
moiety without the need for a chemical cou-
pling step between the host protein and the
organometallic moiety. For synthetic
organometallic chemists, avidin and struc-
turally related streptavidin are attractive
host proteins for several reasons:
i) Derivatization of the valeric acid side
chain of biotin does not significantly af-
fect the stability constant of the biotin-
(strept) avidin couple (Ka = ~1014 M–1)
[2].
ii) The proteins have been cloned and ex-
pressed in several organisms.
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iii) The proteins are easy to purify by affin-
ity chromatography on an iminobiotin
resin [3].
iv) The proteins are very robust (tempera-
ture, pH, organic solvents, etc.) [2].
v) The proteins possess a deep hydrophobic
binding pocket capable of hosting bi-
otinylated catalyst precursors [4][5].
vi) The proteins are easily quantifiable by
titration with fluorescent biotinylated
probes [6].
vii)The protein can be immobilized and/ or
recycled.
Because of the prohibitive cost of pur-
chasing either avidin or streptavidin, we set
out to express these host proteins. Two ma-
jor issues were addressed in this context:
the development of efficient expression sys-
tems and the generation of protein diversity
(i.e. mutagenesis).
Expression Systems
The modern techniques of molecular bi-
ology, the availability of genes and the in-
creasing knowledge of cellular mechanisms
allow the routine utilization of several liv-
ing systems for the expression of exoge-
nous proteins. 
Avidin is a glycoprotein found in avian,
reptilian and amphibian egg white, which
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extracellular secretion of the recombinant
protein. After transformation, high-level
expressing clones are roughly selected
growing transformants on nitrocellulose
filters. The filters are utilized for the dot
blot procedure [17] and colonies that stain
most are utilized for further expression. 
The recombinant avidin is efficiently
produced both in flasks at a concentration
of ~40 mg/l and in a high-cell density fer-
mentation at a concentration of ~350 mg/l
[18]. In this system, the purification of re-
combinant avidin only requires the concen-
tration of the culture medium and its purifi-
cation via an affinity chromatography on an
iminobiotin column.
Streptavidin is the prokaryotic counter-
part of avidin, with the same tridimensional
eight-stranded β-barrel structure, but only
32% protein sequence homology [8]. It is
produced by Streptomyces avidini in its the
extracellular medium and has antimicrobic
activity [19]. As for avidin, the active form
of streptavidin is a homotetramer. Each of
subunit can bind a (+)-biotin molecule with
almost the same affinity as avidin [8][19].
Each monomer consists of 159 amino acids
and the gene of streptavidin was isolated
by Argaraña et al. [20]. The primary source
for the commercial production of strepta-
vidin has been the isolation from cultures
of Streptomyces avidinii [21] or the expres-
sion in recombinant E. coli [22]. Bio-
logically active recombinant streptavidin
has been also secreted in the extracellular
medium in the Bacillus subtilis expression
system [22].
The streptavidin gene is expressed in
E. coli both in shaking flasks and in a 15 l
Mutagenesis method Template DNA treatment Remarks
Site Directed Plasmid Quick change procedure (Stratagene protocol) Sequencing 
Mutagenesis required
Cassette Linear DNA or Excision of sequences corresponding to functional protein regions
Mutagenesis plasmid + High throughput
Site-directed mutagenesis or erratic PCR screen or
+ sequencing
Cloning of PCR product required
DNA shuffling Linear DNA or Random cut of sequences (DNAse I) High throughput
plasmid + screen required
Mutagenic and recombinogenic PCR
+
Cloning of PCR products
Gene synthesis Synthesis of coding Ligation of coding fragments Sequencing required
fragments, based on +
back-translation of Amplification (PCR)
amino acid sequence +
Cloning of PCR product
Table. Summary of the mutagenesis methods utilized for the generation of (strept)avidin diversity.
fermentor. The episomal vectors target
the protein into the cytoplasm. This expres-
sion system was optimized in our group.
The multi-step purification involves a lysis
of the cells by heat shock, an enzymatic di-
gestion of nucleic acids and a denaturing-
renaturing step prior to affinity purification
of the active protein. Under optimized con-
ditions, we routinely obtain a concentration
of active streptavidin of up to 120 mg/l of
fermenting culture.
The expression of avidin in this pro-
karyotic system (i.e. E. coli) is more prob-
lematic, essentially because it is produced
in inclusion bodies [13]. The purification
from inclusion bodies requires an obligato-
ry denaturing-renaturing step and avidin is
not prone to renaturing [13]. 
Mutagenesis
In order to introduce variability in either
avidin or streptavidin, four different ap-
proaches were investigated: i) site-directed
mutagenesis, ii) cassette mutagenesis, iii)
DNA shuffling and iv) artificial gene syn-
thesis (Table). 
(i) The site-directed mutagenesis is uti-
lized for direct deletion, insertion or modi-
fication of sequences. The procedure, based
on PCR, involves two normal primers lo-
cated at the beginning and the end of the tar-
get sequence, and one other longer primer,
complementary to the sequence portions
flanking the zone to modify and bearing the
mutation (mutagenic primer) (Scheme). All
the PCRs required in this technique are per-
formed with a proof-reading DNA poly-
merase. Two PCRs are required. For the
first PCR, an external normal primer and a
mutagenic internal primer are used. After
purification of the product, a second PCR is
performed. This PCR contains as template
the unmodified target sequence, the product
of the previous PCR acting as megaprimer,
and one of the external normal primers. The
result is a complete functional sequence
containing the desired mutation [24]. A
variant of this technique is performed on
the whole expression vector containing the
protein gene. Starting from the site in which
the mutation is introduced, two opposite
primers direct a PCR that resynthesizes the
whole plasmid. This variant usually is car-
ried out with the ‘Quickchange Mutagene-
sis Kit’ (Stratagene) and is considerably
less time-consuming.
Site-directed mutagenesis is essentially
utilized in the E. coli-streptavidin system.
The mutations (single or multiple) are lo-
cated mainly in loop connecting β-sheets
around the biotin-binding pocket. In most
cases, the original amino acid was ex-
changed with a glycine, to confer more
flexibility to the loop.
ii) The cassette mutagenesis is utilized
to completely change one specific region of
a gene. The gene is roughly subdivided
according the position of functional or
structural domains.
Random or site-directed mutations can
be introduced in one or more of these par-
tial sequences (cassettes). Their extremities
maintain a high homology with the original
gene. One or more cassettes are introduced
into the gene by homologous recombina-
tion or by cloning utilizing restriction sites
present in the original sequence. This
method requires a stringent selection of
expressing organism (http://www.kazusa.
or.jp/codon). The resulting coding strand is
subdivided into several fragments. The
length of these fragments along the gene is
chosen to minimize the formation of sec-
ondary structures. Shorter oligomers, on
the antisense strand, are synthesized across
couples of adjacent coding fragments.
These oligomers have the function to align
the coding fragments in the right order. The
coding fragments are subsequently cova-
lently ligated to give a full-length coding
strand. A high-fidelity PCR is performed to
synthesize the antisense strand and obtain
enough material for sequencing and clo-
ning. This method was utilized to test a hy-
pothesis concerning the factors responsible
for enantioselection. Indeed, streptavidin
proved to be far a better chiral inducer than
avidin in the vast majority of experiments.
By way of example, the best enantiomeric
excess (ee) for the reduction of acetami-
doacrylic acid with mutant streptavidin as
host protein affords acetamidoalanine with
96% ee (R) [28]. The best ee with mutant
avidin for the same substrate was only 69%
(S) [29]. Analysis of the quaternary struc-
ture of both proteins reveals that the main
structural difference arises from loop 5-6
which is in close proximity to the catalytic
event (Fig.). We thus set out to synthesize a
chimeric gene, by incorporating the 5-6
loop of streptavidin in the avidin gene. The
resulting chimeric avidin was expressed in
baffled flasks, yielding after purification,
10 mg/l of functional chimeric avidin.
Outlook
By optimizing both the expression lev-
els and the mutagenesis methods, we have
been able to generate diversity in host
proteins for enantioselective catalysis. By
combining the chemical diversity of the
biotinylated catalysts with the genetic
diversity of the protein, it is possible to
produce artificial metalloenzymes which
are amenable to optimization by high
throughput screening methods. 
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functional mutated protein [25]. For both
avidin and streptavidin, the purification
step on an iminobiotin column fulfills this
selection step as only those proteins that
bind to iminobiotin are purified, isolated
and subsequently screened for catalytic ac-
tivity in the presence of a biotinylated cata-
lyst precursor.
iii) The DNA shuffling technique [26]
[27] is utilized to introduce random muta-
tions throughout the avidin or streptavidin
gene. The method implies a random frag-
mentation of the gene or of the genes to be
modified through digestion with an unspe-
cific endonuclease. Re-assembly PCR is
performed combining the fragment isolated
above. In the case of mixing streptavidin
with avidin, the genes of which display on-
ly 30% homology, the first 10–15 cycles of
the PCR are performed manually, alternat-
ing a fast freezing of the denatured DNA
with annealing, elongation and denatura-
tion. After this in vitro recombination, an
aliquot of this PCR is utilized to perform
another normal PCR with primer designed
to insert appropriate restriction sites allow-
ing the creation of a mutant library.
An important step of this procedure is
the screening of the mutant library. In this
phase, functional proteins with new or im-
proved characteristics are selected for the
following cycle of shuffling, starting again
with the random cut. It is clear that in the
case of this technique the screening step
must be a high throughput step. For this
purpose, a 96 well-plate fluorescence
quenching titration with biotin-4-fluores-
cein allows the binding properties and the
activity towards biotin of the mutant pro-
teins to be assessed. It is also possible to
perform the shuffling protocol in vivo, ex-
ploiting the promptness of Pichia to recom-
bination [28]. In this case random frag-
ments are introduced into yeast cell already
containing a gene homologous with the
fragments.
iv) The synthesis of an artificial gene is
utilized to optimize the expression of strep-
tavidin or avidin in a given expression
system. For this purpose, the amino acid
sequence of the gene of interest is back-
translated and the degenerate codons are
selected according to the frequency of the
triplet per amino acid, found in the chosen
Scheme. General scheme of the site-directed mutagenesis proce-
dure for streptavidin
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